Drug-delivery Systems For Local Anesthetics: Therapeutic Applications [formulações De Anestésicos Locais De Liberação Controlada: Aplicações Terapêuticas]

BACKGROUND AND OBJECTIVES: Many researchers in the last four decades have been devoted to the development of drug-delivery systems. Since its first application in the pharmaceutical industry, many results have been obtained especially in the molecular manipulation of carriers and their interaction with encapsulated drugs. These new carriers have the advantage of bypassing encapsulated drugs restraining physicochemical properties (such as water or membrane solubility), thus improving pharmacodynamics (therapeutic effect potentiation), pharmacokinetics (control of tissue absorption and distribution) and toxic effects (lowerlocal and systemic toxicity). Liposomes and cyclodextrins are among the most important carriers which have shown to be quite advantageous in the development of drug-delivery systems for local anesthetics. This study aimed at reviewing the interaction of local anesthetics with liposomes and cyclodextrins, the development of basic and applied research on the field, in addition to therapeutic applicability of these formulations. CONTENTS: Liposomes have the ability to control drug delivery to target tissues, fractionating drug release in its site of action. Cyclodextrins, on the other hand, change intensity and duration of effects due to low systemic drug absorption. Basic and clinical studies have pointed out that the administration of local anesthetics in liposome or cyclodextrin formulations induces slow release of the drugs, prolonging the anesthetic action and decreasing cardiac and nervous systems toxicity. CONCLUSIONS: Although studies are still in progress, drug-delivery systems are flagging a new direction for the development of safer and more effective local anesthetic formulations.535663671Siddall, P.J., Cousins, M.J., Pain mechanisms and management: An update (1995) Clin Exp Pharmacol Physiol, 22, pp. 679-688Bennett, G., Deer, T., Stuart, D.P., Future directions in the management of pain by intraspinal drug delivery (2000) J Pain Symp Manag, 20, pp. 44-50Akerman, B., Arweström, E., Post, C., Local anesthetics potentiate spinal morphine antinociception (1988) Anesth Analg, 67, pp. 943-948Whiteside, J.B., Wildsmith, J.A.W., Developments in local anesthetics drugs (2001) Br J Anaesth, 87, pp. 27-35De Jong, R.H., (1994) Local Anesthetics, 1st Ed, pp. 87-88. , USA, Mosby-Year BookKuzma, P.J., Kline, M.D., Calkins, M.D., Progress in the development of ultra-long-acting local anesthetics (1997) Reg Anesth, 22, pp. 543-551Ranade, V.V., Drug delivery systems. 1. Site-specific drug delivery using liposomes as carriers (1989) J Clin Pharmacol, 29, pp. 685-694Lichtenberg, D., Barenholz, Y., Liposomes - Preparation, characterization and preservation (1988) Method Biochem Anal, 33, pp. 337-462Grant, G.J., Bansinath, M., Liposomal delivery systems for local anesthetics (2001) Reg Anesth Pain Med, 26, pp. 61-63Sharata, H.H., Katz, K.H., Liposomes (1996) Int J Dermatol, 35, pp. 761-769Malinovsky, J.-M., Benhamou, D., Alafandy, M., Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits (1997) Anesth Analg, 85, pp. 1331-1336Rongen, H.A.H., Bult, A., Van Bennekom, W.P., Liposomes and immunoassays (1997) J Immunol Meth, 204, pp. 105-133Law, S.L., Huang, K.J., Chiang, C.H., Acyclovir-containing liposomes for potential ocular delivery corneal penetration and absorption (2000) J Control Release, 63, pp. 135-140Kotwani, R.N., Gokhale, P.C., Bodhe, P.V., A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates (2002) Int J Pharm, 238, pp. 11-15Erridge, C., Stewart, J., Bennet-Guerrero, The biological activity of a liposomal complete core lipopolysacharide vaccine (2002) J Endotoxin Res, 8, pp. 39-46Stuart, D.D., Kao, G.Y., Allen, T., A novel long-circulating and functional liposomal formulation of antisense oligonucleotides targeted against MDR1 (2000) Cancer Gene Therapy, 7, pp. 466-475Boogaerts, J., Declercq, A., Lafont, N., Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: Comparision with plain solutions (1993) Anesth Analg, 76, pp. 553-555Boogaerts, J.G., Lafont, N.D., Luo, H.C., Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits (1993) Can J Anaesth, 40, pp. 1201-1204Yu, H.-Y., Sun, P., Hou, W.-Y., Prolonged local anesthetic effect of bupivacaine liposomes in rats (1998) Int J Pharm, 176, pp. 133-136Malinovsky, J.M., Bernard, J.M., Baudriment, M., A chronic model for experimental investigation of epidural anesthesia in the rabbit (1997) Reg Anesth, 22, pp. 80-85Malinovsky, J.M., Le Corre, P., Meunier, J.F., A dose-response study of liposomal bupivacaine in rabbits (1999) J Contr Rel, 60, pp. 111-119Boogaerts, J.G., Lafont, N.D., Declerq, A.G., Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: A first study (1994) J Clin Anesth, 6, pp. 315-320Lafont, N.D., Legros, F.J., Boogaerts, J.G., Use of liposome-associated bupivacaine in a cancer pain syndrome (1996) Anaesthesia, 51, pp. 578-579Simonetti, M.P.B., Andrade, M.P., Anestėsicos Iocais e opióides encapsulados em lipossomas: Um avanço farmacológico em progresso (1996) Rev Bras Anestesiol, 46, pp. 35-42Langerman, L., Grant, G.J., Zakowski, M., Prolongation of epidural anesthesia using a lipid carrier with procaine, lidocaine and tetracaine (1992) Anesth Analg, 75, pp. 900-905Mowat, J.J., Mok, M.J., MacLeod, B.A., Liposomal bupivacaine (1996) Anesthesiol, 85, pp. 635-643Loftsson, T., Masson, M., Cyclodextrins in topical drug formulations: Theory and practice (2001) Int J Pharm, 225, pp. 15-30Matioli, G., (2000) Ciclodextrinas e Suas Aplicações em Alimentos, Fármacos, Agricultura, Biotecnologia, Química Analítica e Produtos Gerais. 1a Ed, pp. 3-5. , Maringá, EduemMcCormack, B., Gregoriadis, G., Drugs-in-cyclodextrins-in-liposomes: An approach to controlling the fate of water insoluble drugs in vivo (1998) Int J Pharmac, 162, pp. 59-69Bibby, D., Davies, N.M., Tucker, I.G., Mechanisms by wich cyclodextrins modify drug release from polymeric drug delivery systems (2000) Int J Pharmac, 197, pp. 1-11Kalinkova, G.N., Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations (1999) Int J Pharm, 187, pp. 1-15Frömming, K.-H., Szejtli, J., (1994) Topics in Inclusion Science Cyclodextrins in Pharmacy, 1st Ed, pp. 50-51. , Hungria, Kluwer Academic PublishersKirchmeier, M.J., Ishida, T., Chevrette, J., Correlations between the rate of intracellular release of endocytosed liposomal doxorubicin and cytotoxicity as determined by a new assay (2001) J Liposome Res, 11, pp. 15-29Veiga, F., Fernandes, C., Teixeira, F., Oral availability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes (2000) Int J Pharm, 202, pp. 165-171Dalmora, M.E., Dalmora, S.L., Oliveira, A.G., Inclusion complex of piroxicam with β-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect (2001) Int J Pharm, 222, pp. 45-55Irie, T., Uekama, K., Pharmaceutical applications of ciclodextrins. III. Toxicological issues and safety evaluation (1997) J Pharm Sci, 86, pp. 147-162Rajewski, R.A., Stella, V.J., Pharmaceutical applications of cyclodextrins. 2. In vivo Drug delivery (1996) J Pharm Sci, 85, pp. 1142-1169Dollo, G., Le Corre, P., Chevanne, F., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. I. Physicochemical characterization (1996) Int J Pharmac, 131, pp. 219-228Dollo, G., Le Corre, P., Chevanne, F., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. II. Evaluation of affinity constants and in vitro transfer rate constants (1996) Int J Pharmac, 136, pp. 165-174Fréville, J.C., Dollo, G., Le Corre, P., Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex (1996) Pharm Res, 13, pp. 1576-1580Dollo, G., Thompson, D.O., Le Corre, P., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. III. Biopharmaceutics of bupivacaine-SBE7-β-ciclodextrina complex following percutaneous sciatic nerve administration in rabbits (1998) Int J Pharmac, 164, pp. 11-19Dollo, G., Le Corre, P., Freville, J.C., Biopharmaceutics of local anesthetic cyclodextrin complexes following loco-regional administration (2000) Ann Pharm Fr, 58, pp. 425-432Fletcher, D., Le Corre, P., Guilbaud, G., Antinociceptive effect of bupivacaine encapsulated in poly(D,L)-lactide-co-glycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats (1997) Anesth Analg, 84, pp. 90-94Garry, M.G., Jackson, D.L., Geier, H.E., Evaluation of the efficacy of a bupivacaine polymer system on nociception and inflammatory mediator release (1999) Pain, 82, pp. 49-55Kohane, D.S., Lipp, M., Kinney, R.C., Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine (2000) Pharm Res, 17, pp. 1243-1249Grant, G.J., Barenholz, Y., Piskoun, B., DRV liposomal bupivacaine: Preparation, characterization and in vivo evaluation in mice (2001) Pharm Res, 18, pp. 336-34